Ramesh Saxena

Ramesh Saxena, M.D., Ph.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center, specializing in nephrology with a focus on lupus nephritis, glomerulonephritis, and peritoneal dialysis. He holds roles as Medical Director of the Davita Irving Dialysis Center and serves on key committees including the Clinician Educator Compensation Plan Committee and the Clinical Competency Committee for Renal Fellows. His professional affiliations include membership in the American Society of Nephrology and the International Society of Peritoneal Dialysis, alongside editorial board roles for the Journal of Vascular Access.

• Education: M.D. from Maulana Azad Medical College (India), Ph.D. in autoimmune glomerulonephritis from Lund University (Sweden)
• Residencies: Internal Medicine at Northeastern Ohio University College of Medicine
• Fellowships: Postdoctoral at Case Western Reserve University, Nephrology at The Ohio State University

Research Interests: Saxena’s work centers on biomarkers for lupus nephritis, chronic kidney disease management, and peritoneal dialysis optimization. His studies explore molecular mechanisms of autoimmune kidney diseases and clinical applications of novel therapeutic strategies.

Publications Trends: His articles emphasize biomarker discovery (e.g., urinary sCD163, angiostatin), clinical trials for lupus nephritis treatment (voclosporin), and innovative approaches to peritoneal dialysis. Recent work highlights interdisciplinary collaboration in regenerative medicine and stem cell therapies.

• Scientific Awards: 2012 and 2015 Excellence in Teaching Awards from UT Southwestern
• Professional Recognition: Fellow of the American Society of Nephrology

Advising & Grants: While no explicit grants are listed, Saxena mentors renal fellows and contributes to clinical documentation improvement initiatives. He actively participates in free clinics and professional education programs.

Labs/Teams: The Saxena Lab collaborates with institutions like Case Western Reserve University and the Ohio State University, focusing on translational research in nephrology and autoimmune diseases.